Correlation Between Regeneron Pharmaceuticals and Spring Valley

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Spring Valley at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Spring Valley into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Spring Valley Acquisition, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Spring Valley and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Spring Valley. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Spring Valley.

Diversification Opportunities for Regeneron Pharmaceuticals and Spring Valley

-0.6

Correlation Coefficient

Regeneron Pharmaceuticals  Spring Valley

Excellent diversification

The 3 months correlation between Regeneron and Spring is -0.6. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Spring Valley Acquisition in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spring Valley Acquisition and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Spring Valley. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spring Valley Acquisition has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Spring Valley go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Spring Valley

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to generate 6.14 times less return on investment than Spring Valley. But when comparing it to its historical volatility, Regeneron Pharmaceuticals is 2.75 times less risky than Spring Valley. It trades about 0.17 of its potential returns per unit of risk. Spring Valley Acquisition is currently generating about 0.38 of returns per unit of risk over similar time horizon. If you would invest  40.00  in Spring Valley Acquisition on September 14, 2025 and sell it today you would earn a total of  37.00  from holding Spring Valley Acquisition or generate 92.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	42.19%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Spring Valley Acquisition

Regeneron Pharmaceuticals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Regeneron Pharmaceuticals are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent technical and fundamental indicators, Regeneron Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Spring Valley Acquisition

Risk-Adjusted Performance

Strong

Over the last 90 days Spring Valley Acquisition has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively weak forward indicators, Spring Valley reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Regeneron Pharmaceuticals and Spring Valley

The main advantage of trading using opposite Regeneron Pharmaceuticals and Spring Valley positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Spring Valley can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spring Valley will offset losses from the drop in Spring Valley's long position.

The idea behind Regeneron Pharmaceuticals and Spring Valley Acquisition pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.